{"log_id": 4034522041861992794, "direction": 0, "words_result_num": 38, "words_result": [{"probability": {"variance": 0.005481, "average": 0.980037, "min": 0.508826}, "location": {"width": 805, "top": 232, "height": 58, "left": 228}, "words": "WHI单用雌激素亚组研究中,经过平均7.1年的随访,CEE(每天0.625mg)与侵润性"}, {"probability": {"variance": 0.008823, "average": 0.974309, "min": 0.439051}, "location": {"width": 516, "top": 271, "height": 49, "left": 226}, "words": "乳腺癌风险增加没有关系(RR0.80,95%nC0.62-1.04"}, {"probability": {"variance": 0.00806, "average": 0.969287, "min": 0.479559}, "location": {"width": 796, "top": 314, "height": 60, "left": 233}, "words": "WHI雌激素加孕激素亚组中,平均随访5.6年后,报告有侵润性乳腺癌风险增加(RR"}, {"probability": {"variance": 0.001315, "average": 0.986016, "min": 0.81838}, "location": {"width": 809, "top": 342, "height": 63, "left": 229}, "words": "124,95%nCI101-1.54);雌孕激素联合组中发现的侵润性乳腺癌比安慰剂组中发现"}, {"probability": {"variance": 0.01117, "average": 0.956217, "min": 0.5898}, "location": {"width": 821, "top": 371, "height": 63, "left": 228}, "words": "的大,诊断时分期也较晚。雌孕激素组与安慰剂组的绝对风险分别为41对33例每000"}, {"probability": {"variance": 9.5e-05, "average": 0.996412, "min": 0.940534}, "location": {"width": 819, "top": 400, "height": 63, "left": 230}, "words": "人年。转移病灶罕见,组间没有明显差异。其他预后因素如组织学分型,分级和激素"}, {"probability": {"variance": 0.000199, "average": 0.995292, "min": 0.944473}, "location": {"width": 313, "top": 450, "height": 43, "left": 230}, "words": "受体状况等在组间没有明显差异"}, {"probability": {"variance": 6e-06, "average": 0.998614, "min": 0.990044}, "location": {"width": 811, "top": 485, "height": 62, "left": 232}, "words": "流行病学研究报告使用雌激素或雌激素加孕激素进行激素治疗几年的妇女乳腺癌风险"}, {"probability": {"variance": 0.000111, "average": 0.996475, "min": 0.936751}, "location": {"width": 824, "top": 514, "height": 62, "left": 232}, "words": "增加。风险随使用时间而增加,并似乎在停止治疗5年后逐渐恢复到基线水平。这些研"}, {"probability": {"variance": 0.000515, "average": 0.99002, "min": 0.878465}, "location": {"width": 810, "top": 545, "height": 59, "left": 234}, "words": "究还提示使用雌孕激素联合治疗比单独使用雌激素乳腺癌风险高,而且风险的增加更"}, {"probability": {"variance": 2e-06, "average": 0.998645, "min": 0.996474}, "location": {"width": 113, "top": 603, "height": 27, "left": 235}, "words": "早表现出来"}, {"probability": {"variance": 0.007831, "average": 0.97771, "min": 0.503937}, "location": {"width": 818, "top": 627, "height": 62, "left": 234}, "words": "评价不同HRT配方的研究,无论雌激素/孕激素成分、剂量、方案和给药途径,均没有"}, {"probability": {"variance": 0.000303, "average": 0.985492, "min": 0.955699}, "location": {"width": 130, "top": 652, "height": 35, "left": 925}, "words": "约商务部"}, {"probability": {"variance": 0, "average": 0.999124, "min": 0.998195}, "location": {"width": 291, "top": 677, "height": 40, "left": 235}, "words": "显示出乳腺癌风险的显著差异"}, {"probability": {"variance": 0.000515, "average": 0.992483, "min": 0.868318}, "location": {"width": 819, "top": 711, "height": 61, "left": 237}, "words": "根据流行病学研究的数据,预计从未使用过HRT的妇女,每1000名妇女有32名在50-65"}, {"probability": {"variance": 0.000195, "average": 0.995844, "min": 0.910541}, "location": {"width": 814, "top": 740, "height": 62, "left": 236}, "words": "岁间诊断出乳腺癌。在1000名正在或近期使用单独雌激素治疗的妇女中,从50岁开始"}, {"probability": {"variance": 0.003937, "average": 0.98908, "min": 0.592397}, "location": {"width": 812, "top": 772, "height": 57, "left": 238}, "words": "使用5年和10年,预计至65岁时诊断出的乳腺癌分别增加1.5%和5%使用雌激素加孕"}, {"probability": {"variance": 0.002369, "average": 0.986565, "min": 0.733791}, "location": {"width": 819, "top": 799, "height": 60, "left": 237}, "words": "激素联合治疗者的相应数字是6%和19%。有报告指出单用雌激素或使用雌激素加孕激"}, {"probability": {"variance": 2e-06, "average": 0.998883, "min": 0.995279}, "location": {"width": 421, "top": 843, "height": 45, "left": 237}, "words": "素导致需要进一步评估的异常乳腺摄片增加"}, {"probability": {"variance": 1.5e-05, "average": 0.998175, "min": 0.978346}, "location": {"width": 814, "top": 881, "height": 62, "left": 239}, "words": "所有妇女应每年由医务人员进行乳房检查,每月进行乳房自检。此外,应根据患者年"}, {"probability": {"variance": 0.000256, "average": 0.994931, "min": 0.927533}, "location": {"width": 415, "top": 926, "height": 46, "left": 239}, "words": "龄和风险因素,计划安排进行乳房X线检查"}, {"probability": {"variance": 3e-06, "average": 0.99908, "min": 0.990283}, "location": {"width": 821, "top": 994, "height": 61, "left": 244}, "words": "在一些流行病学研究中,使用单独雌激素产品,尤其是使用达10年或更长时间,与卵"}, {"probability": {"variance": 0.04419, "average": 0.830756, "min": 0.515851}, "location": {"width": 106, "top": 996, "height": 28, "left": 244}, "words": "e.卵巢癌"}, {"probability": {"variance": 0.001401, "average": 0.987325, "min": 0.824683}, "location": {"width": 821, "top": 1023, "height": 63, "left": 242}, "words": "巢癌风险增加相关。其他流行病学研究没有发现这种相关性。WI数据分析提示雌激"}, {"probability": {"variance": 1e-06, "average": 0.999193, "min": 0.995123}, "location": {"width": 352, "top": 1070, "height": 45, "left": 245}, "words": "素加孕激素治疗可能增加卵巢癌风险"}, {"probability": {"variance": 0.000118, "average": 0.994511, "min": 0.957078}, "location": {"width": 810, "top": 1136, "height": 61, "left": 245}, "words": "妇女健康行动记忆研究( WHIMS),WHI的一项附属研究,一个人群组为4,532名65"}, {"probability": {"variance": 0.000832, "average": 0.981488, "min": 0.931563}, "location": {"width": 84, "top": 1139, "height": 27, "left": 209}, "words": "4.痴呆"}, {"probability": {"variance": 0.000145, "average": 0.994365, "min": 0.940629}, "location": {"width": 809, "top": 1166, "height": 59, "left": 248}, "words": "79岁妇女,随机分配到CEE加MPA(每天0.625mg/2.5mg)组或安慰剂组。第二个人"}, {"probability": {"variance": 0.002492, "average": 0.985097, "min": 0.669143}, "location": {"width": 797, "top": 1195, "height": 59, "left": 246}, "words": "群组为2,947名65-79岁子宫切除妇女,随机分配到CEE(每天0.625mg)或安慰剂组"}, {"probability": {"variance": 0.000555, "average": 0.993648, "min": 0.85219}, "location": {"width": 823, "top": 1222, "height": 60, "left": 248}, "words": "平均随访4年后,雌激素加孕激素组与安慰剂组相比,报告的可能性痴呆的相对风险为"}, {"probability": {"variance": 0.007367, "average": 0.963544, "min": 0.584067}, "location": {"width": 819, "top": 1251, "height": 60, "left": 245}, "words": "205(95%CI1.21-3.48)。在单用雌激素组,平均随访5.2年后,与安慰剂相比,报告"}, {"probability": {"variance": 0.007904, "average": 0.971217, "min": 0.545285}, "location": {"width": 823, "top": 1280, "height": 60, "left": 247}, "words": "的可能性痴呆的相对风险为1.49(95%CI0.83-2.66)。当按照WHMS方案所计划的将"}, {"probability": {"variance": 0.005002, "average": 0.967677, "min": 0.639233}, "location": {"width": 810, "top": 1311, "height": 57, "left": 249}, "words": "两组人群的数据合并,可能性痴呆的总体相对风险报告为1.76(95%C1.19-2.60}。因"}, {"probability": {"variance": 1.5e-05, "average": 0.998399, "min": 0.97673}, "location": {"width": 818, "top": 1338, "height": 60, "left": 251}, "words": "为该研究是在65-79岁的妇女中进行的,这些结果是否适用于较年轻的绝经后妇女还不"}, {"probability": {"variance": 0.000308, "average": 0.988468, "min": 0.940391}, "location": {"width": 218, "top": 1391, "height": 35, "left": 249}, "words": "清楚(见[老年用药])"}, {"probability": {"variance": 0.000405, "average": 0.989005, "min": 0.933379}, "location": {"width": 197, "top": 1446, "height": 38, "left": 215}, "words": "5.妊娠期间的影响"}, {"probability": {"variance": 0.020989, "average": 0.91303, "min": 0.397335}, "location": {"width": 634, "top": 1454, "height": 57, "left": 252}, "words": "妊娠期间不应使用雌激素见[禁忌和孕妇及哺乳期女用药"}, {"probability": {"variance": 0.006629, "average": 0.94163, "min": 0.78387}, "location": {"width": 126, "top": 1535, "height": 25, "left": 217}, "words": "6.胆囊疾病"}], "language": 3}